Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Eastern Cooperative Oncology Group Performance Status Questionnaire

Known as: ECOG, ECOG1 
Eastern Cooperative Oncology Group (ECOG) Performance Status (Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Background Patients diagnosed with stage 4 non-small cell lung cancer (NSCLC) have poor survival (median 9–12 months). A platinum… Expand
2017
2017
Clinical benefit of a treatment demonstrated in patients with metastatic cancer leads to an optimistic and, understandably… Expand
2014
2014
Amiodarone is an antiarrhythmic drug that is commonly used for the treatment of ventricular and supraventricular arrhythmias. It… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2013
2013
  • G. Sinha
  • Journal of the National Cancer Institute
  • 2013
  • Corpus ID: 205184321
one?” asked Abbruzzese. “We are just now making our first assessment of a portfolio of clinical trials from the steering… Expand
2013
2013
Background Capecitabine is indicated in colon cancer alone or in combination. Recommended posology is calculated with reference… Expand
Highly Cited
2013
Highly Cited
2013
BACKGROUND HSP90 inhibition leads to proteosomal degradation of activated KIT and has in vitro activity against gastrointestinal… Expand
2012
2012
Background: HSP90 inhibition leads to proteosomal degradation of activated KIT and has in vitro activity against gastrointestinal… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3